about
Structural Features and Anti-coagulant Activity of the Sulphated Polysaccharide SPS-CF from a Green Alga Capsosiphon fulvescens.What are the anticoagulation options for intermittent hemodialysis?Alternatives to standard unfractionated heparin for pediatric hemodialysis treatmentsManagement of heparin-induced thrombocytopenia.Chronic fondaparinux use in a hemodialysis patient with heparin-induced thrombocytopenia type II and extracorporeal circuit thrombosis-a case report and review of the literature.Polyethyleneimine-treated polyacrylonitrile membrane hemofilter for critically ill patients receiving anticoagulant-free prolonged intermittent renal replacement therapy: a single-center, prospective, self-controlled pilot study.Contrast-induced acute kidney injury and renal support for acute kidney injury: a KDIGO summary (Part 2).Tinzaparin reduces health care resource use for anticoagulation in hemodialysis.Quantitative Determination of High Charge Density Polyanion Contaminants in Biomedical Heparin Preparations Using Potentiometric Polyanion Sensorsc-Kit signaling determines neointimal hyperplasia in arteriovenous fistulaeClinical experience with nadroparin in patients undergoing dialysis for renal impairment.Oversulfated chondroitin sulfate is a contaminant in heparin associated with adverse clinical events.The effect of citrate dialysate on intradialytic heparin dose in haemodialysis patients: study design of a randomised controlled trialCitrate- vs. acetate-based dialysate in bicarbonate haemodialysis: consequences on haemodynamics, coagulation, acid-base status, and electrolytesDetection of high-charge density polyanion contaminants in biomedical heparin preparations using potentiometric polyanion sensors.Drug-induced thrombosis: an update.Anticoagulation in Chronic Hemodialysis: Progress Toward an Optimal Approach.Intermittent saline flushes or continuous saline infusion: what works better when heparin-free dialysis is recommended?Effect of nadroparin on anti-Xa activity during nocturnal hemodialysis.Antiplatelet and oral anticoagulant therapies in chronic hemodialysis patients: prescribing practices and bleeding risk.Antiplatelet, anticoagulant, and profibrinolytic activities of baicalin.Superior outcome of nafamostat mesilate as an anticoagulant in patients undergoing maintenance hemodialysis with intracerebral hemorrhage.Characterization of currently marketed heparin products: key tests for quality assurance.Inhibition of urinary macromolecule heparin on aggregation of nano-COM and nano-COD crystals.Renal unit practitioners' knowledge, attitudes and practice regarding the safety of unfractionated heparin for chronic haemodialysis.Determination of galactosamine impurities in heparin samples by multivariate regression analysis of their (1)H NMR spectra.
P2860
Q30991437-FC564FCC-4F47-4F7A-AF18-5339169DA4BFQ33396089-FD10CE93-D80C-4AF0-83AE-96D25A04DFD0Q33399961-D7E95C8F-FCB3-4B55-A23C-1870AFF1838DQ33400573-B9256A23-4B68-415C-B6BC-FFC9C553AE29Q33404712-2F589427-8AEE-484E-95C8-B0F016CC9540Q33443163-D0AAD291-69AE-472F-88B6-5FEA9C8B3FADQ33752736-78CFA64D-D201-4585-B2F5-2EBB1FB3A884Q33825694-7B04D3D9-AE1C-4F57-9534-31F0C70CD5BCQ34386506-8ACBFC54-9867-4E5B-9CDC-0A83287A1FC5Q34439804-EB9DEA19-2FD5-4404-9A74-830E4B5F4112Q34630740-03FD1583-1223-4D4B-AECA-7965EFC563E5Q34774203-53FDAF6A-5845-4404-B302-6E3263658D8EQ35754027-8C66822C-74BF-4E9A-A6CF-16527B737811Q37132012-65E51F3A-B92A-4CDF-8EE2-CFA5EB72069CQ37327548-0D7FD175-CE55-4534-8171-925FA15C589DQ38103820-720364F1-FF6B-4969-AE66-34193C7F5457Q38442992-61D63827-85B8-4BF3-ADC7-31FF4A48B994Q40039240-9A760780-2676-448A-A20B-B9081DDEACA8Q40207102-F894E93F-DC34-4BEB-AE63-29E103F68565Q40773906-B08BD3CA-1158-42D0-913D-3DAD103F83A3Q42217401-2EBDAAD0-BB72-4856-884A-004C7EBB7597Q43265108-39A0C252-99B7-4038-833C-ADEDFDC20359Q43952782-9CD77E38-C69B-41C5-9F0E-D50EF72DFB98Q46282194-707BF921-4686-430F-B375-264E68FD66E8Q46571673-5C66E381-52DC-4964-98AC-CF14B0AE6B54Q51646753-939FF836-D3ED-481B-8B7C-FC8C5A9E320E
P2860
description
2007 nî lūn-bûn
@nan
2007 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Essentials of anticoagulation in hemodialysis.
@ast
Essentials of anticoagulation in hemodialysis.
@en
type
label
Essentials of anticoagulation in hemodialysis.
@ast
Essentials of anticoagulation in hemodialysis.
@en
prefLabel
Essentials of anticoagulation in hemodialysis.
@ast
Essentials of anticoagulation in hemodialysis.
@en
P2860
P1476
Essentials of anticoagulation in hemodialysis.
@en
P2093
Karl-Georg Fischer
P2860
P304
P356
10.1111/J.1542-4758.2007.00166.X
P577
2007-04-01T00:00:00Z